Skip to main content
VCbacked
Log inGet Started

Anjarium Biosciences

Schlieren, Switzerland

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

$60.4M raised
Sep 2021
Series A
BiotechnologyPharmaceutical

Top Investors

AbingworthPfizer Venture InvestmentsOmega FundsGimvSurveyor Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anjarium Biosciences

How much funding has Anjarium Biosciences raised?
Anjarium Biosciences has raised $60.4M in total funding. The most recent round was Series A. The last funding was announced in September 2021.
Who are Anjarium Biosciences's investors?
Anjarium Biosciences's investors include Abingworth, Pfizer Venture Investments, Omega Funds, Gimv, Surveyor Capital.
Where is Anjarium Biosciences headquartered?
Anjarium Biosciences is headquartered in Schlieren, Switzerland.
What does Anjarium Biosciences do?
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
What stage is Anjarium Biosciences at?
Anjarium Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Anjarium Biosciences — Funding & Investors." VCBacked, September 15, 2021, https://www.vcbacked.co/company/anjarium-biosciences. Accessed July 1, 2026.
APA
VCBacked. (2021). Anjarium Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/anjarium-biosciences
Wikipedia (cite web)
{{cite web |title=Anjarium Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/anjarium-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K